Teladoc Health annual gross margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Teladoc Health's gross margin was 69.50% for fiscal 2025.
View full Teladoc Health company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 69.50% | −1.26 pp |
| 2024 | 2024-12-31 | 70.76% | −0.03 pp |
| 2023 | 2023-12-31 | 70.80% | +1.71 pp |
| 2022 | 2022-12-31 | 69.09% | +1.08 pp |
| 2021 | 2021-12-31 | 68.01% | +3.74 pp |
| 2020 | 2020-12-31 | 64.27% | −2.39 pp |
| 2019 | 2019-12-31 | 66.66% | −2.53 pp |
| 2018 | 2018-12-31 | 69.20% | −4.39 pp |
| 2017 | 2017-12-31 | 73.58% | −0.46 pp |
| 2016 | 2016-12-31 | 74.04% | +1.23 pp |
| 2015 | 2015-12-31 | 72.81% | −4.38 pp |
| 2014 | 2014-12-31 | 77.19% | −1.78 pp |
| 2013 | 2013-12-31 | 78.97% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 68.56% | −1.29 pp |
| Q1 2026 | 2026-03-31 | 67.82% | −0.90 pp |
| Q4 2025 | 2025-12-31 | 69.32% | −1.18 pp |
| Q3 2025 | 2025-09-30 | 70.12% | −1.82 pp |
| Q2 2025 | 2025-06-30 | 69.85% | −0.88 pp |
| Q1 2025 | 2025-03-31 | 68.73% | −1.17 pp |
| Q4 2024 | 2024-12-31 | 70.50% | −0.21 pp |
| Q3 2024 | 2024-09-30 | 71.94% | +0.10 pp |
| Q2 2024 | 2024-06-30 | 70.73% | −0.07 pp |
| Q1 2024 | 2024-03-31 | 69.89% | +0.10 pp |
| Q4 2023 | 2023-12-31 | 70.72% | +0.33 pp |
| Q3 2023 | 2023-09-30 | 71.83% | +2.19 pp |
| Q2 2023 | 2023-06-30 | 70.79% | +1.60 pp |
| Q1 2023 | 2023-03-31 | 69.79% | +2.87 pp |
| Q4 2022 | 2022-12-31 | 70.38% | +1.95 pp |
| Q3 2022 | 2022-09-30 | 69.64% | +2.04 pp |
| Q2 2022 | 2022-06-30 | 69.20% | +1.05 pp |
| Q1 2022 | 2022-03-31 | 66.92% | −0.91 pp |
| Q4 2021 | 2021-12-31 | 68.43% | +0.50 pp |
| Q3 2021 | 2021-09-30 | 67.60% | +3.86 pp |
| Q2 2021 | 2021-06-30 | 68.15% | +5.81 pp |
| Q1 2021 | 2021-03-31 | 67.83% | +7.86 pp |
| Q4 2020 | 2020-12-31 | 67.93% | +3.30 pp |
| Q3 2020 | 2020-09-30 | 63.74% | −5.24 pp |
| Q2 2020 | 2020-06-30 | 62.34% | −5.71 pp |
| Q1 2020 | 2020-03-31 | 59.97% | −5.29 pp |
| Q4 2019 | 2019-12-31 | 64.63% | −2.76 pp |
| Q3 2019 | 2019-09-30 | 68.98% | −0.23 pp |
| Q2 2019 | 2019-06-30 | 68.04% | −2.68 pp |
| Q1 2019 | 2019-03-31 | 65.25% | −4.79 pp |
| Q4 2018 | 2018-12-31 | 67.39% | −3.16 pp |
| Q3 2018 | 2018-09-30 | 69.21% | −6.40 pp |
| Q2 2018 | 2018-06-30 | 70.72% | −6.79 pp |
| Q1 2018 | 2018-03-31 | 70.04% | −1.66 pp |
| Q4 2017 | 2017-12-31 | 70.55% | −2.64 pp |
| Q3 2017 | 2017-09-30 | 75.61% | −2.42 pp |
| Q2 2017 | 2017-06-30 | 77.52% | +3.53 pp |
| Q1 2017 | 2017-03-31 | 71.70% | +1.24 pp |
| Q4 2016 | 2016-12-31 | 73.20% | +1.81 pp |
| Q3 2016 | 2016-09-30 | 78.04% | +0.51 pp |
| Q2 2016 | 2016-06-30 | 73.98% | +0.20 pp |
| Q1 2016 | 2016-03-31 | 70.46% | +2.49 pp |
| Q4 2015 | 2015-12-31 | 71.38% | — |
| Q3 2015 | 2015-09-30 | 77.53% | −2.75 pp |
| Q2 2015 | 2015-06-30 | 73.78% | −6.51 pp |
| Q1 2015 | 2015-03-31 | 67.97% | — |
| Q3 2014 | 2014-09-30 | 80.28% | — |
| Q2 2014 | 2014-06-30 | 80.30% | — |
Over the last five fiscal years, Teladoc Health's gross margin increased from 64.27% to 69.50%, a change of +5.23 percentage points. The latest reported quarter, Q2 2026, shows 68.56%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Teladoc Health source filings ↗